The context-dependent role of the dsRNA response in linking A-to-I editing and ADAR to normal hematopoiesis and leukemia. [PDF]
Li X, Xu J, Yu J.
europepmc +1 more source
Two codes of RNA editing by deamination in human diseases. [PDF]
Min DJ, Lee S, Lee YS, Cho J.
europepmc +1 more source
A-to-I RNA Editing Endows miR-3664-5p with Carcinogenicity in Breast Cancer Through Modulating LONP2 Mediated Glycolysis. [PDF]
Han Y, Wei X, Zhang X, Wu J, Wang F.
europepmc +1 more source
The regulatory mechanism and clinical significance of RNA editing in prostate cancer. [PDF]
Li S +10 more
europepmc +1 more source
Evolution of Engineered ADAR-Based RNA Editing Systems. [PDF]
Borkiewicz L.
europepmc +1 more source
RNA editing in cardiovascular health and disease. [PDF]
Huang X, Solomon C, McVey DG, Ye S.
europepmc +1 more source
Structural and mechanistic basis of ADAR1-mediated RNA editing and immune regulation. [PDF]
Deng X, Elsharkawy M, Gao Y.
europepmc +1 more source
RNA editing: an emerging frontier in cancer therapy - explorations, opportunities, and challenges. [PDF]
Chen J +9 more
europepmc +1 more source
Context-dependent modulation of the TAK1-MAPK axis by ginsenoside-based formulations along the NAFLD-HCC continuum. [PDF]
Lim HK, Oh JY, Chung KN, Yoo BC, Cho JY.
europepmc +1 more source
RNA-TITER-An ADAR-based transcript detection assay for accelerated functional titer assessment of adeno-associated viruses. [PDF]
Rothgangl T +5 more
europepmc +1 more source

